Connect with us

Technology

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Published

on

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

BURLINGTON, Mass., July 22, 2024 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide comprehensive proteomics profiling on up to 20,000 individuals, underscoring Azenta’s commitment to advancing healthcare innovation and personalized treatments. Azenta will use Olink’s advanced proteomics technology, based on the proprietary Proximity Extension Assay, to provide high-quality protein-level measurements across all major biological pathways.

“FinnGen’s adoption of proteomics marks a pivotal advancement in our quest to decode the complexities of human health and disease. By integrating the dynamic insights of proteomics with our extensive genomic data, we can gain a deeper understanding of disease mechanisms, identify new biomarkers for early detection, and uncover novel therapeutic targets. We are pleased to collaborate with Azenta Life Sciences, and trust that they will provide excellent service and deliver high-quality proteomic data with a fast turnaround time,” said Professor Aarno Palotie, FinnGen Scientific Director from the Institute for Molecular Medicine Finland (FIMM), University of Helsinki. “Combined with excellent quality and reliable results, Azenta Life Sciences can help us construct a strong foundation for advancing the field of personalized medicine.”

“As one of the collaborators in the FinnGen Project, Azenta looks forward to making meaningful contributions to personalized medicine and revolutionizing healthcare for generations to come,” said Ginger Zhou, PhD., Senior Vice President and General Manager, GENEWIZ Multiomics & Synthesis Solutions from Azenta Life Sciences. “Multiomics technologies from Azenta enable researchers to efficiently generate detailed proteomics data from study participants carrying medically and clinically significant genetic variants, opening up a world of possibilities for understanding disease mechanisms and developing targeted treatments.”

About FinnGen

FinnGen is a large public-private partnership aiming to collect and analyze genome and health data from 500,000 Finnish biobank participants. FinnGen aims on one hand to provide novel medically and therapeutically relevant insights but also construct a world-class resource that can be applied for future studies.

FinnGen is one of the very first personalized medicine projects at this scale and the public-private collaborative nature of the project is exceptional compared to many ongoing studies. FinnGen brings together Finnish universities, hospitals and hospital districts, THL, Blood Service, biobanks, FINBB and international pharmaceutical companies and hundreds of thousands of Finns. Because collaboration is the key to achieving breakthroughs in disease prevention, diagnosis, and treatment, we welcome everyone on this journey into our shared heritage.

For more information, please visit https://www.finngen.fi/en.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry’s top pharmaceutical, biotech, academic, and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.

Azenta is headquartered in Burlington, Massachusetts, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

“Safe Harbor Statement” under Section 21E of the Securities Exchange Act of 1934

Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Azenta’s financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. Other forward-looking statements include but are not limited to statements about the prospects of the FinnGen Project and our ability to contribute to the advancement of personalized medicine. Factors that could cause results to differ from our expectations include the following: changes in technology and/or science that impact our ability to enable researchers to generate the proteomics data required to understand disease and develop targeted treatments and other factors and other risks, including those that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, Current Reports on Form 8-K and our Quarterly Reports on Form 10-Q. As a result, we can provide no assurance that our future results will not be materially different from those projected. Azenta expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions, or circumstances on which any such statement is based. Azenta undertakes no obligation to update the information contained in this press release.

INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

Azenta’s use of third-party trademarks and brands are for identification only and does not imply affiliation or endorsement. All trademarks used herein are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/finngen-selects-azenta-to-propel-personalized-medicine-for-population-health-study-302203113.html

SOURCE Azenta

Continue Reading

Technology

The Next Frontier: Consciousness & UAP: $100,000 Research Prize Winner Announced

Published

on

By

The Institute of Noetic Sciences (IONS) has announced the winner of the 2026 Linda G. O’Bryant Noetic Sciences Research Prize, a $100,000 award that will fund a study of consciousness-associated Unidentified Anomalous Phenomena (UAP, formerly known as UFOs).

NOVATO, Calif., Nov. 5, 2026 /PRNewswire-PRWeb/ — The winning study, selected from more than 80 qualifying proposals, comes from a multidisciplinary team of six. Peter Skafish, PhD, a sociocultural anthropologist and Co-Founder and Executive Director of The Sol Foundation, leads the team as Principal Investigator. Brian Lord, PhD, a cognitive neuroscientist and postdoctoral researcher at the University of Arizona, serves as Co-Principal Investigator, and David Dominguez Hooper, engineer and Founder and CEO of ELDAEON Inc., is Co-Investigator. Collaborators are Damon Abraham, PhD (experimental psychologist, Entangled Labs); Jacob Haqq-Misra, PhD (astrobiologist, Blue Marble Space); and Garry Nolan, PhD (immunologist, Stanford University School of Medicine). For the first time in the prize’s four-year history, a single team will receive the full $100,000.

“IONS proved itself to be over the horizon of even heterodox thinking in their decision to fund a scientific inquiry not only into UAP but also into one of the most enigmatic questions the phenomena raise: what is their relationship to human consciousness?”–Peter Skafish

The team will organize a group of experienced practitioners to apply meditation and conscious intention to invite contact with UAP at a remote site in the American Southwest. Practitioners’ experiences will be recorded alongside physiological measures and instrumental records of the sky and the physical environment. Using preregistered methodology, the study will analyze the data to test whether deliberate contact practice generates changes in reported experiences and in independently recorded events in the sky and environment. De-identified data and methods will be shared openly, and null results will be released on the same schedule as positive ones.

According to IONS leadership, this year’s prize was created to bring UAP into open, consciousness-inclusive science, and to carry forward a question with profound implications for humanity that its founder, Apollo 14 astronaut Edgar Mitchell, pursued for decades: whether consciousness and contact are connected.

“The Sol Foundation couldn’t be more happy to receive the recognition of IONS for our research,” said Peter Skafish. “IONS proved itself to be over the horizon of even heterodox thinking in their decision to fund a scientific inquiry not only into UAP but also into one of the most enigmatic questions the phenomena raise: what is their relationship to human consciousness?”

This year, distinguished external experts, including Daniel P. Sheehan, Jessica Utts, Adam Curry, Sean Esbjörn-Hargens, Richard Dolan, and J.J. Hurtak, joined members of the IONS science team on the judging panel, chaired by Arnaud Delorme. The panel’s selection was then ratified by the IONS Board of Directors.

IONS researchers will collaborate with the winning team on the study, which is expected to begin in December and run for one year, with results to be shared in 2028. The winning team was announced on October 30 during a live event, which can be watched here.

More About IONS & the Linda G. O’Bryant Noetic Sciences Research Prize

The Institute of Noetic Sciences (IONS) is a nonprofit scientific research center whose mission is to reveal the interconnected nature of reality through scientific exploration and personal discovery. Founded in 1973 by Apollo 14 astronaut Edgar Mitchell, IONS investigates consciousness, interconnectedness, and extended human capacities to help foster a more compassionate and thriving world. The Linda G. O’Bryant Noetic Sciences Research Prize, now in its fourth year, is funded through an endowment created by Linda G. O’Bryant, member of the IONS Board of Directors, and overseen by the Board. To arrange an interview with Peter Skafish or IONS leadership, contact communications@noetic.org. More details about the prize and winners can be found here.

Media Contact

Leslie G. Lovejoy, Institute of Noetic Sciences (IONS), 1 707-775-3500, communications@noetic.org, www.noetic.org

View original content:https://www.prweb.com/releases/the-next-frontier-consciousness–uap-100-000-research-prize-winner-announced-302930915.html

SOURCE Institute of Noetic Sciences (IONS)

Continue Reading

Technology

Budget 2026 advances national electricity strategy, a downpayment on unlocking $3 trillion in economic growth

Published

on

By

Proposed tax credit extensions and support for industrial electrification and EV charging can help build more clean power and put it to work

OTTAWA, ON, Nov. 5, 2026 /CNW/ — New Economy Canada strongly supports the finalization and funding of Powering Canada Strong in Budget 2026 with a $50 billion commitment, marking an important step toward doubling Canada’s electricity supply by 2050. Budget 2026 puts electrification at the heart of Canada’s economy, ensuring energy security and affordability for businesses and households.  

Ian Bruce, President of New Economy Canada said:

“Today we are celebrating a critical win for Canada. By finalizing and funding Powering Canada Strong, the federal government has made electricity an economic priority.  Budget 2026’s $50B commitment to doubling the grid, including strengthening and extending the clean economy investment tax credits, is a significant step.

Budget 2026 puts an electrified economy at the heart of Canada’s economic strategy. We are glad to see the federal government recognize that building more clean electricity, electrifying more of our economy, and improving energy efficiency are some of the most effective ways to build a competitive, strong economy and ensure energy security for businesses and households alike.

Our economic report shows the opportunity on the table. Doubling electricity supply and doubling the share of energy that homes, businesses and industry meet with electricity could add more than $3 trillion cumulatively to Canada’s economy by 2050. Getting there will take sustained investment and a workforce that can build projects at the pace and scale we need.”

Why this matters:

Affordable, clean electricity can help Canada win investment, strengthen competitiveness, modernize manufacturing and create jobs. As Canada looks for new investors and trading partners in an electrifying global economy, its abundant, affordable and clean electricity is a competitive advantage.Doubling Canada’s electricity supply and putting it to work could unlock $3 trillion of economic opportunity for Canada and 1.6 million jobs.The budget’s extension of investment tax credits will support much-needed investment in generating and transmitting more electricity. And support for industrial electrification and EV charging will help businesses and households make greater use of that power.Every province stands to benefit, with cross-sectoral growth. Growth associated with an electrified economy spans all provinces and beyond electricity generation to services, mining, construction and more. 

New Economy Canada is a non-partisan initiative uniting 70+ companies, labour unions and Indigenous organizations, all committed to accelerating investment in Canada’s clean economy. Our partners employ or represent over 750,000 workers. https://neweconomycanada.ca 

SOURCE New Economy Canada

Continue Reading

Technology

East Side Games Group to Announce Third Quarter 2026 Financial Results

Published

on

By

VANCOUVER, BC, Nov. 5, 2026 /CNW/ — East Side Games Group (“ESGG” or the “Company”), Canada’s leading free-to-play mobile game group, will release its third quarter ended September 30th, 2026, after market close on November 12th. Following the release, the Company will host a conference call to review its performance with the investment community at 3:30pm PT (Western Canada), 2:30pm PT, 5:30pm ET on the same day.

Related earnings release materials can be found in the Investors section of ESGG’s website at https://eastsidegamesgroup.com/investors/financial-information/.

Conference Call Details:

Toll Free Dial-In Number:       (+1) 800 717 1738
Local Dial-In Number:            (+1) 289 514 5100
Conference ID:                       53358

A replay will be available by dialing (+1) 888 660-6264 or (+1) 289 819-1325 and entering passcode 53358#.

ABOUT EAST SIDE GAMES GROUP

ESGG is a leader in free-to-play mobile gaming, thrilling players with unforgettable experiences that spark lifelong fandom. Fueled by an entrepreneurial spirit, we are driven by creativity, flawless execution, and a laser-focused growth strategy. We develop and publish both original and licensed IP titles, license our cutting-edge GameKit(s) platforms, and strategically acquire studios or games to expand our family. Headquartered in Vancouver with around 80 talent-dense team members, we operate over a dozen titles under East Side Games (“ESG”) and LDRLY (Technologies) Inc. (“LDRLY”). Together, we’re crafting, launching, and publishing mobile games across our own studios and an extended Game Kit partner network–reaching players on iOS and Android worldwide.

We power our success through in-app purchases (“IAP”)–offering exclusive, game-enhancing virtual items–and in-game advertising. To keep growing, we focus on captivating audiences, keeping them engaged, and unlocking exciting new ways to monetize. We’ll drive this momentum by launching bold new titles, enriching our current lineup, innovating discovery, expanding into fresh markets and exploring new distribution platforms.

Additional information about the Company continues to be available under its legal name, East Side Games Group Inc., at www.sedar.com.

Forward-looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the proposed transactions described herein. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management’s current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including factors beyond the Company’s control. These forward-looking statements are made as of the date of this news release.

SOURCE East Side Games Group Inc.

Continue Reading

Trending